Plasma urate concentrations and possible REM sleep behavior disorder.
Journal
Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
11
09
2019
revised:
26
09
2019
accepted:
27
09
2019
pubmed:
13
11
2019
medline:
2
10
2020
entrez:
13
11
2019
Statut:
ppublish
Résumé
To examine how urate concentrations are related to the risk of having possible REM sleep behavior disorder (pRBD) in a community-based cohort. The study included 12,923 Chinese adults of the Kailuan Study, free of Parkinson disease (PD) and dementia. Plasma urate concentrations were measured in 2006, 2008, and 2010. Cumulative average urate concentration was used as primary exposure. In 2012, we determined pRBD status using a validated RBD questionnaire-Hong Kong (RBDQ-HK). Logistic regression analysis was performed to estimate the association between urate concentrations during 2006-2010 and odds of having pRBD in 2012 or pRBD case with symptom onset within 1 year. Higher average urate concentrations were associated with a lower odds of pRBD (P-trend <0.001). The adjusted odds ratio (OR), for the highest versus lowest urate quintiles, was 0.43 (95% confidence intervals (CIs) 0.32-0.57). Significant association was consistently observed when we examined the association of a single urate assessment (2006 or 2010) or the rate of change in urate concentrations during 2006-2010 with pRBD (P-trend <0.001 for all). However, restricting to pRBD onset during 2011-2012, we observed a nonsignificant trend between high urate concentration and high odds of pRBD (P-trend = 0.09). Higher average urate concentrations were associated with a lower likelihood of having pRBD, but not new-onset pRBD. Because of its observational study design, the result should be interpreted with caution due to the possibility of residual confounding.
Identifiants
pubmed: 31714690
doi: 10.1002/acn3.50929
pmc: PMC6917330
doi:
Substances chimiques
Uric Acid
268B43MJ25
Types de publication
Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2368-2376Subventions
Organisme : Institute for CyberScience Seed Grant Program
ID : Penn State University
Pays : International
Organisme : Jiangsu Provincial social development projects
ID : BE2018658
Pays : International
Organisme : college of health and human development and the department of nutritional sciences
ID : Penn State University
Pays : International
Organisme : National Key R&D Program of China
ID : 2017YFC0909100
Pays : International
Informations de copyright
© 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
Références
Stroke. 2018 Jan;49(1):27-33
pubmed: 29229723
J Neurochem. 2002 Jan;80(1):101-10
pubmed: 11796748
Exp Neurol. 2017 Nov;297:138-147
pubmed: 28821398
Sleep Med. 2013 Aug;14(8):754-62
pubmed: 23474058
Exp Neurol. 2017 Dec;298(Pt B):210-224
pubmed: 28622913
Sleep Med. 2010 Jan;11(1):43-8
pubmed: 19945912
Neurosci Lett. 2017 Sep 14;657:102-105
pubmed: 28801272
Am J Epidemiol. 2008 Apr 1;167(7):831-8
pubmed: 18326873
Mov Disord. 2013 Jul;28(8):1150-1
pubmed: 23536471
Parkinsonism Relat Disord. 2018 Aug;53:4-9
pubmed: 29789205
Arch Neurol. 2009 Dec;66(12):1460-8
pubmed: 19822770
Mediators Inflamm. 2017;2017:4573756
pubmed: 28831208
Am J Epidemiol. 2009 May 1;169(9):1064-9
pubmed: 19299404
J Neurochem. 2012 Oct;123(1):172-81
pubmed: 22671773
Arch Neurol. 2008 Jun;65(6):716-23
pubmed: 18413464
Ann Neurol. 2005 Nov;58(5):797-800
pubmed: 16240356
J Neural Transm (Vienna). 2018 Dec;125(12):1805-1812
pubmed: 30284075
Hypertension. 2017 Sep;70(3):508-514
pubmed: 28716992
Curr Neurol Neurosci Rep. 2012 Aug;12(4):367-75
pubmed: 22580741
Lancet Neurol. 2016 Jun;15(7):708-718
pubmed: 27039162
Am J Epidemiol. 1996 Sep 1;144(5):480-4
pubmed: 8781463
PLoS One. 2012;7(5):e37331
pubmed: 22606360
Ann Neurol. 2014 Dec;76(6):862-8
pubmed: 25257975
Ann N Y Acad Sci. 2010 Jan;1184:15-54
pubmed: 20146689
Lancet. 2009 Jun 13;373(9680):2041-53
pubmed: 19524780
Sleep. 2013 Nov 01;36(11):1579-85
pubmed: 24179289
Anesthesiology. 2008 May;108(5):812-21
pubmed: 18431116
Arthritis Care Res (Hoboken). 2017 May;69(5):703-708
pubmed: 27454342
Brain. 2015 May;138(Pt 5):1263-70
pubmed: 25732183
Ann Clin Transl Neurol. 2018 Aug 18;5(10):1176-1183
pubmed: 30349852
Neurology. 2018 Oct 30;91(18):e1710-e1715
pubmed: 30258025
Ann Neurol. 2018 Aug;84(2):191-199
pubmed: 30014513
Nat Rev Neurol. 2016 Oct 27;12(11):622-634
pubmed: 27786242
Sleep Med. 2014 Aug;15(8):952-8
pubmed: 24938584
Qual Life Res. 2002 Dec;11(8):817-21
pubmed: 12482165
PLoS One. 2015 Dec 14;10(12):e0143697
pubmed: 26658438
J Pain Symptom Manage. 2011 May;41(5):904-14
pubmed: 21420272
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):300-5
pubmed: 23248282
Neurology. 2016 Apr 5;86(14):1306-1312
pubmed: 26819459
Parkinsonism Relat Disord. 2018 Jul;52:49-54
pubmed: 29606606
Am J Epidemiol. 2007 Sep 1;166(5):561-7
pubmed: 17584757
Neurology. 2017 May 9;88(19):1849-1855
pubmed: 28389588
Neurology. 2016 Feb 9;86(6):520-6
pubmed: 26764029
Neurology. 2015 Nov 17;85(20):1761-8
pubmed: 26475692
Brain. 2019 Mar 1;142(3):744-759
pubmed: 30789229